MMedXYNews
Ask AIHomeVideos
MedXY AI/MedXY News/Section: Cardiology
Cardiology

Superior Durability of Dedicated Balloon-Expandable Bridging Stents in BEVAR: Insights from the BeGraft Peripheral Plus Study

MedXY Editorial TeamJan 1, 2026
vascular surgery

Highlights

  • Exceptional technical success was achieved in 99.3% of 2,418 target visceral vessels.
  • The estimated two-year primary patency rate for the BeGraft Peripheral Plus (BGP+) was 95.8%.
  • Target vessel instability, a critical metric for long-term success, was observed in only 2.9% of cases.
  • Freedom from branch-related re-intervention remained high at 98.4% at the two-year mark.

Introduction: The Evolution of Complex Aortic Repair

MedXY registered readers

Sign in free to continue reading

Create or use your MedXY account to unlock the complete article.

This article was created using several editorial tools, including AI, as part of the process. Human editors reviewed this content before publication.

Related articles

Enhanced Cardiovascular Risk Prediction Through Combined LDL-C, Lp(a), and hsCRP Assessment in a Multiethnic Population

CardiologyNov 5, 2026

Anticoagulation in Octogenarians with Atrial Fibrillation: Balancing Mortality Benefits and Bleeding Risks

CardiologyNov 4, 2026

Impact of Subtypes and Ventriculocoronary Connections on Hypoplastic Left Heart Syndrome Outcomes: Insights from the Fetal Heart Society Multicenter Study

CardiologyNov 4, 2026
Loading comments...

Most read

  1. 01Intimate Health

    Five Benefits for Women Continuing Sexual Activity After Menopause

  2. 02Intimate Health

    Why Some Women Have a Strong Sex Drive—And Why Men Shouldn't Worry About It

  3. 03Nursing & care

    How often should a couple have sex?

  4. 04Cardiology

    Precision Medicine for Long QT Syndrome Type 2: Lumacaftor Corrects Trafficking Defects and Shortens QT Interval

  5. 05General Surgery

    Optimizing Postoperative Opioid Prescriptions After Intra-Abdominal Cancer Surgery: Comparing the 5x-Multiplier and 3-Tier Models

Go deeper with MedXY AI

Explore the evidence behind the news.

Ask AI
MedXY briefing

Stay informed

Medical news and research updates, delivered to your inbox.

© 2026 MedXY
Contact usAbout usPrivacy PolicyMedXY story